Iovance Biotherapeutics, Inc. (IOVA) vs Rhythm Pharmaceuticals, Inc. (RYTM)
- Iovance Biotherapeutics, Inc. IOVA 13.58 −7.74%
- Rhythm Pharmaceuticals, Inc. RYTM 86.17 −2.05%
Iovance Biotherapeutics, Inc. and Rhythm Pharmaceuticals, Inc. are both Biotechnology companies. Iovance Biotherapeutics, Inc. is the larger, with a market value of $6.7B against $6.1B — 1.1× the size. Rhythm Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 53.5% against 34.6%. Rhythm Pharmaceuticals, Inc. has the higher net margin (−87.6% vs −89.1%) and the higher return on invested capital (0.00% vs −43.0%). Across the 16 metrics below, Rhythm Pharmaceuticals, Inc. leads on 9 and Iovance Biotherapeutics, Inc. on 7.
Valuation
Profitability
| Metric | IOVA | RYTM | Biotechnology median |
|---|---|---|---|
| Gross margin | 48.40% | 89.00% | 65.16% |
| Operating margin | (92.72%) | (83.62%) | 0.00% |
| Net margin | (89.09%) | (87.62%) | 0.00% |
| Free cash flow margin | (91.21%) | (43.91%) | 0.00% |
| Return on equity | (40.36%) | (461.65%) | (56.36%) |
| Return on assets | (31.76%) | (51.91%) | (48.04%) |
| Return on invested capital | (42.96%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack